证券代码：688478 证券简称：晶升股份 公告编号：2024-036 一、 回购股份的基本情况 公司于 2024 年 2 月 19 日召开第二届董事会第三次会议，审议通过《关于以 集中竞价交易方式回购公司股份方案的议案》，同意公司使用自有资金通过上海证 券交易所交易系统以集中竞价交易方式回购公司部分股份，回购资金总额不低于 人民币 5,000 万元（含），不超过人民币 1 亿元（含）；回购价格不超过人民币 56.40 元/股（含）；回购期限自公司董事会审议通过本次回购公司股份方案之日起 12 个 月内。 具体内容详见公司分别于 2024 年 2 月 20 日、2024 年 2 月 23 日披露于上海证 券交易所网站（www.sse.com.cn）的《南京晶升装备股份有限公司关于以集中竞 价交易方式回购公司股份方案的公告》（公告编号：2024-011）、《南京晶升装备股 份有限公司关于以集中竞价交易方式回购公司股份的回购报告书》（公告编号： 2024-014）。 二、 回购股份的进展情况 根据《上市公司股份回购规则》《上海证券交易所上市公司自律监管指引第 7 号——回购股份》的相关规定，公司在回购期间，应当于 ...

证券代码：688478 证券简称：晶升股份 公告编号：2024-037 特此公告。 南京晶升装备股份有限公司董事会 南京晶升装备股份有限公司（以下简称"公司"）于 2024 年 4 月 29 日、2024 年 5 月 21 日分别召开第二届董事会第五次会议及 2023 年年度股东大会，审议通 过了《关于修订<公司章程>并办理工商变更登记的议案》，同意对《南京晶升装 备股份有限公司章程》（以下简称"《公司章程》"）部分条款进行修订完善，并授 权公司管理层指派公司相关人员办理工商变更登记备案手续等相关事宜。 具体内容详见公司分别于 2024 年 4 月 30 日、2024 年 5 月 22 日在上海证券 交易所网站（www.sse.com.cn）披露的《公司章程》《南京晶升装备股份有限公司 关于修订<公司章程>并办理工商变更登记、制定及修订部分内部管理制度的公 告》（公告编号：2024-027）、《南京晶升装备股份有限公司 2023 年年度股东大会 决议公告》（公告编号：2024-035）。 近日，公司已完成相关的工商变更登记以及修订后的《公司章程》备案工作。 南京晶升装备股份有限公司 关于完成工商变更登记及《公 ...

证券代码：688478 证券简称：晶升股份 公告编号：2024-035 南京晶升装备股份有限公司 2023 年年度股东大会决议公告 本公司董事会及全体董事保证公告内容不存在任何虚假记载、误导性陈述或 者重大遗漏，并对其内容的真实性、准确性和完整性依法承担法律责任。 重要内容提示： 本次会议是否有被否决议案：无 一、 会议召开和出席情况 （一） 股东大会召开的时间：2024 年 5 月 21 日 （二） 股东大会召开的地点：江苏省南京经济技术开发区红枫科技园 B4 栋西侧， 公司会议室 （三） 出席会议的普通股股东、特别表决权股东、恢复表决权的优先股股东及 其持有表决权数量的情况： | 1、出席会议的股东和代理人人数 | 13 | | --- | --- | | 普通股股东人数 | 13 | | 2、出席会议的股东所持有的表决权数量 | 82,790,230 | | 普通股股东所持有表决权数量 | 82,790,230 | | 3、出席会议的股东所持有表决权数量占公司表决权数量的比 | 60.2703 | | 例（%） | | | 普通股股东所持有表决权数量占公司表决权数量的比例（%） | 60.2703 | ...

上海市锦天城（南京）律师事务所 关于南京晶升装备股份有限公司 2023年年度股东大会的 法律意见书 地址：南京市建邺区江东中路 347 号国金中心一期 27、28 楼 电话：025-68515000 传真：025-68516601 邮编：210019 上海市锦天城（南京）律师事务所 法律意见书 上海市锦天城（南京）律师事务所 法律意见书 上海市锦天城（南京）律师事务所 关于南京晶升装备股份有限公司 2023年年度股东大会的 法律意见书 致：南京晶升装备股份有限公司 上海市锦天城（南京）律师事务所（以下简称"本所"）接受南京晶升装备股 份有限公司（以下简称"公司"）委托，就公司召开2023年年度股东大会（以下简 称"本次股东大会"）的有关事宜，根据《中华人民共和国公司法》（以下简称《公 司法》）、《上市公司股东大会规则》等有关法律、法规、规范性文件以及《南京 晶升装备股份有限公司章程》（以下简称《公司章程》）的有关规定，出具本法律 意见书。 为出具本法律意见书，本所及本所律师依据《律师事务所从事证券法律业务管 理办法》和《律师事务所证券法律业务执业规则（试行）》等规定，严格履行了法 定职责，遵循了勤勉尽责和诚实 ...

证券代码：688478 证券简称：晶升股份 公告编号：2024-034 根据《上市公司股份回购规则》《上海证券交易所上市公司自律监管指引第 7 号——回购股份》的相关规定，公司在回购期间，应当于每个月的前 3 个交易日 内公告截至上月末的回购进展情况。现将公司回购进展情况公告如下： 截至 2024 年 4 月 30 日，公司通过上海证券交易所交易系统以集中竞价交易 方式已累计回购公司股份 661,565 股，占公司总股本的比例为 0.4781%，回购成交 的最高价为 35.70 元/股，最低价为 25.11 元/股，已支付的资金总额为人民币 20,088,868.34 元（不含印花税、交易佣金等交易费用）。 | 回购方案首次披露日 | 2024/2/20 | | --- | --- | | 回购方案实施期限 | 自公司董事会审议通过之日起 12 个月内 | | 预计回购金额 | 50,000,000.00 元~100,000,000.00 元 | | 回购用途 | □减少注册资本 √用于员工持股计划或股权激励 | | | □用于转换公司可转债 | | | □为维护公司价值及股东权益 | | 累计已回购股数 | ...

证券代码：688478 证券简称：晶升股份 公告编号：2024-033 南京晶升装备股份有限公司 关于参加 2023 年度半导体设备专场集体业绩说明会 暨 2024 年第一季度业绩说明会的公告 本公司董事会及全体董事保证本公告内容不存在任何虚假记载、误导性陈 述或者重大遗漏，并对其内容的真实性、准确性和完整性承担法律责任。 重要内容提示： 会议召开时间：2024 年 5 月 15 日(星期三) 下午 15:00- 17:00 会议召开地点：上海证券交易所上证路演中心（网址： https://roadshow.sseinfo.com/） 会议召开方式：网络文字互动 投资者可于 2024 年 5 月 14 日(星期二)16:00 前通过公司邮 箱（cgee@cgee.com.cn）进行提问。公司将在文字互动环节对投资 者普遍关注的问题进行回答。 南京晶升装备股份有限公司（以下简称"公司"）已于 2024 年 4 月 30 日在上海证券交易所网站（www.sse.com.cn）披露了公司 2023 年年度报告以及 2024 年第一季度报告，为便于广大投资者更 全面深入地了解公司 2023 年度及 2024 年第一季 ...

Dividend and Profit Distribution - The company plans to distribute a cash dividend of RMB 2.00 per 10 shares, totaling RMB 27,610,993.00 (including tax) based on a total share capital of 138,054,965 shares after deducting repurchased shares[5]. - The board of directors has approved the profit distribution plan, which is subject to shareholder approval[6]. Financial Performance - The company has not achieved profitability since its listing, indicating ongoing investment and growth strategies[4]. - The company reported a significant increase in revenue for 2023, reaching RMB 1.2 billion, representing a growth of 25% compared to the previous year[16]. - The company achieved a revenue of approximately ¥405.57 million in 2023, representing an increase of 82.70% compared to ¥221.99 million in 2022[24]. - Net profit attributable to shareholders reached approximately ¥71.02 million, up 105.63% from ¥34.54 million in the previous year[24]. - The net profit after deducting non-recurring gains and losses was approximately ¥42.39 million, reflecting an 86.64% increase from ¥22.71 million in 2022[24]. - Basic and diluted earnings per share increased by 69.70% to ¥0.56 from ¥0.33 in 2022[25]. - The company's total assets grew by 245.65% to approximately ¥2.11 billion, compared to ¥610.40 million at the end of 2022[27]. - The net assets attributable to shareholders increased by 204.06% to approximately ¥1.58 billion from ¥520.62 million in the previous year[26]. - The company achieved a main business revenue of RMB 405.57 million in 2023, representing a year-on-year growth of 82.69%[36]. - The company reported a significant increase in sales volume and efficiency, contributing to the overall financial performance improvement[26]. Research and Development - Investment in R&D increased by 15%, totaling RMB 150 million, focusing on advanced semiconductor technologies[16]. - Research and development expenses accounted for 9.37% of total revenue, slightly up from 9.35% in 2022[25]. - R&D expenses increased by 83.10% to CNY 38.02 million, reflecting a significant investment in innovation[110]. - The increase in R&D expenses was primarily due to higher personnel costs, increased material investments, and additional travel expenses related to new product development[76]. - The company is committed to maintaining a high level of R&D investment to sustain its core competitiveness in the market[76]. - The company has a total of 11 ongoing R&D projects, with investments ranging from ¥190 million to ¥600 million, aimed at enhancing the efficiency and quality of silicon and silicon carbide production[78]. Market Expansion and Strategy - The company provided a positive outlook for 2024, projecting a revenue growth of 20% driven by new product launches and market expansion[16]. - The company plans to expand its market presence in Southeast Asia, targeting a 10% market share by 2025[16]. - A strategic acquisition of a local semiconductor firm was announced, expected to enhance production capacity by 40%[16]. - The company aims to become a leader in the domestic semiconductor crystal growth equipment sector, contributing to the development of China's semiconductor industry[34]. - The company has established stable partnerships with leading domestic silicon wafer manufacturers, enhancing its market position and product supply capabilities[66]. Operational Efficiency and Cost Management - Gross margin improved to 35%, up from 30% in the previous year, due to cost optimization strategies[16]. - The company aims to reduce operational costs by 10% through automation and process improvements[16]. - The company has implemented new strategies to improve operational efficiency, which is expected to reduce costs by 5% in the upcoming year[179]. Risks and Compliance - The company has outlined potential risks in its management discussion and analysis section, advising investors to be cautious[4]. - The company faces risks related to technology research and development, including potential failures in product technology upgrades and slow R&D progress, which could negatively impact its market competitiveness[95]. - The company is exposed to financial risks, including accounts receivable collection risks and inventory impairment risks, which could affect asset quality and profitability[100][101]. - The company is committed to improving its governance structure and ensuring compliance with relevant laws and regulations to protect stakeholder interests[163]. Corporate Governance - The company has not disclosed any special arrangements for corporate governance, indicating standard practices are in place[7]. - The company held 1 annual general meeting and 3 extraordinary general meetings during the reporting period, ensuring compliance with regulations to protect minority shareholders' rights[164]. - The company adhered to information disclosure regulations, ensuring that all shareholders had equal access to information, thereby protecting investor interests[168]. - The board of directors emphasized investor relations management, utilizing multiple channels to enhance communication with investors, particularly small and medium-sized investors[169].

Financial Performance - The company's operating revenue for Q1 2024 reached ¥81,107,784.99, representing a year-on-year increase of 111.29%[5] - Net profit attributable to shareholders was ¥14,817,697.06, a significant increase of 507.43% compared to the same period last year[5] - The net cash flow from operating activities was ¥71,185,103.18, reflecting a year-on-year increase of 277.02%[5] - Basic earnings per share were ¥0.11, up 450.00% from the previous year[6] - The company reported a significant increase in profit due to higher sales revenue and increased investment income[10] - In Q1 2024, the company reported a net profit of CNY 14,817,697.06, a significant increase from CNY 2,439,410.75 in Q1 2023, representing a growth of approximately 508%[20] - Operating profit for Q1 2024 was CNY 15,761,541.01, compared to CNY 2,124,147.86 in the same period last year, indicating a year-over-year increase of about 642%[20] - Total revenue from sales and services received in cash was CNY 151,112,872.83, a substantial increase from CNY 28,347,869.45 in Q1 2023, indicating a growth of approximately 433%[22] Assets and Liabilities - Total assets at the end of the reporting period were ¥2,100,341,967.70, a slight decrease of 0.45% from the end of the previous year[6] - The total assets of the company as of March 31, 2024, were RMB 2,100,341,967.70, slightly down from RMB 2,109,856,954.53 at the end of 2023, a decrease of 0.3%[16] - The total liabilities decreased to RMB 508,229,678.59 as of March 31, 2024, from RMB 526,864,684.20 at the end of 2023, a reduction of 3.5%[16] Cash Flow - The company's cash and cash equivalents as of March 31, 2024, amounted to RMB 182,489,632.01, up from RMB 171,945,939.01 as of December 31, 2023, indicating a growth of 7.6%[14] - The company generated cash inflows from operating activities amounting to CNY 152,413,224.77, up from CNY 28,675,369.44 in Q1 2023, marking a growth of approximately 431%[23] - Cash flow from investing activities showed a net outflow of CNY 49,418,228.53, slightly worsening from a net outflow of CNY 48,087,122.99 in Q1 2023[24] - The company’s cash and cash equivalents at the end of Q1 2024 totaled CNY 182,489,632.01, a significant increase from CNY 11,244,922.37 at the end of Q1 2023[24] Research and Development - Total R&D investment amounted to ¥10,651,828.44, which is 13.13% of operating revenue, a decrease of 4.49 percentage points year-on-year[6] - Research and development expenses rose to CNY 10,651,828.44 in Q1 2024, compared to CNY 6,762,077.19 in Q1 2023, an increase of approximately 57%[20] Shareholder Information - The number of ordinary shareholders at the end of the reporting period was 6,712[11] - The top ten shareholders held a combined 57.70% of the company's shares, with the largest shareholder owning 15.88%[11] Financial Management - The weighted average return on equity increased to 0.93%, up by 0.46 percentage points[6] - The company incurred financial expenses of CNY -324,797.17 in Q1 2024, a decrease from CNY -44,920.13 in Q1 2023, reflecting improved financial management[20] - The company reported investment income of CNY 2,269,246.05 in Q1 2024, up from CNY 612,166.68 in the previous year, representing a growth of about 270%[20]

证券代码：688478 证券简称：晶升股份 公告编号：2024-021 南京晶升装备股份有限公司 首次公开发行部分限售股及部分战略配售限售股 上市流通公告 本公司董事会及全体董事保证本公告内容不存在任何虚假记载、误导性陈述 或者重大遗漏，并对其内容的真实性、准确性和完整性依法承担法律责任。 重要内容提示： 本次股票上市类型为首发战略配售股份（限售期 12 月）；股票认购方式为 网下，上市股数为 2,761,377 股。南京晶升装备股份有限公司（以下简称"公司" 或"晶升股份"）确认，上市流通数量等于该限售期的全部战略配售股份数量。 本次股票上市类型为首发限售股份；股票认购方式为网下，上市股数为 58,743,370 股。 本次股票上市流通总数为 61,504,747 股。 本次股票上市流通日期为 2024 年 4 月 24 日。 一、本次上市流通的限售股类型 根据中国证券监督管理委员会于 2023 年 3 月 13 日出具的《关于同意南京晶 升装备股份有限公司首次公开发行股票注册的批复》（证监许可〔2023〕547 号）， 公司获准首次公开发行人民币普通股（A 股）34,591,524 股，并于 2023 年 ...

核查意见 华泰联合证券有限责任公司关于 南京晶升装备股份有限公司首次公开发行部分限售股及部 分战略配售限售股上市流通事项的核查意见 华泰联合证券有限责任公司（以下简称"华泰联合证券"或"保荐机构"） 作为南京晶升装备股份有限公司（以下简称"晶升股份"或"公司"）首次公开 发行股票并在科创板上市持续督导阶段的保荐机构，根据《证券发行上市保荐业 务管理办法》《科创板上市公司持续监管办法（试行）》《上海证券交易所科创板 股票上市规则》《上海证券交易所科创板上市公司自律监管指引第 1 号——规范 运作》等有关规定，对晶升股份首次公开发行部分限售股及部分战略配售限售股 上市流通事项情况进行了认真、审慎的核查，并发表本核查意见，具体情况如下： 一、本次限售股份申请上市流通的基本情况 根据中国证券监督管理委员会于 2023 年 3 月 13 日出具的《关于同意南京晶 升装备股份有限公司首次公开发行股票注册的批复》（证监许可〔2023〕547 号）， 公司获准首次公开发行人民币普通股（A 股）34,591,524 股，并于 2023 年 4 月 24 日在上海证券交易所科创板上市。公司首次公开发行股票完成后，总股本为 138 ...